Theratechnologies Files 6-K Report
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Sep 5, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 6-K, press-release
TL;DR
Theratechnologies filed a 6-K, check the press release for deets.
AI Summary
Theratechnologies Inc. filed a Form 6-K on September 5, 2025, reporting information for the month of September 2025. The filing includes a press release dated September 5, 2025, as Exhibit 99.1. The company is a foreign private issuer based in Montreal, Quebec, Canada.
Why It Matters
This filing provides an update on Theratechnologies' regulatory disclosures, which is important for investors tracking the company's ongoing reporting obligations.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that typically contains press releases or other information required by regulatory bodies, not material financial events.
Key Players & Entities
- Theratechnologies Inc. (company) — Registrant
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary
- September 5, 2025 (date) — Filing date and press release date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically used to furnish information that the issuer makes or is required to make public in its home country.
What exhibit is included with this 6-K filing?
Exhibit 99.1, a Press Release Dated September 5, 2025, is included with this filing.
Where is Theratechnologies Inc. headquartered?
Theratechnologies Inc. is headquartered in Montreal, Quebec, Canada.
Who signed this 6-K report on behalf of Theratechnologies Inc.?
Jocelyn Lafond, General Counsel and Corporate Secretary, signed the report on behalf of Theratechnologies Inc.
What is the SEC file number for Theratechnologies Inc.?
The SEC file number for Theratechnologies Inc. is 001-35203.
Filing Stats: 151 words · 1 min read · ~1 pages · Grade level 11.1 · Accepted 2025-09-05 15:32:55
Filing Documents
- d42031d6k.htm (6-K) — 8KB
- d42031dex991.htm (EX-99.1) — 21KB
- g42031g0905193426854.jpg (GRAPHIC) — 5KB
- 0001193125-25-197146.txt ( ) — 37KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. THERATECHNOLOGIES INC. By: /s/ Jocelyn Lafond Name: Jocelyn Lafond Title: General Counsel and Corporate Secretary Date: September 5, 2025